Peptide Dosages

Contents

Quickstart Highlights

Ipamorelin 5mg + Tesamorelin 5mg (10mg Blend) dosage protocol combines two growth-hormone–oriented peptides for research into lean muscle support, fat reduction, and potential metabolic improvements.

  • Commonly dosed daily or 5 days per week for convenient scheduling
  • Synergistic approach to stimulate growth hormone release
  • Reconstitution volume typically 2–3 mL to maintain practical “units”
  • Store lyophilized in the freezer; refrigerate after reconstitution
  • Useful for examining combined effects on body composition
Ipamorelin 5mg + Tesamorelin 5mg (10mg Blend Vial)
📘 Important: Before viewing any protocol, please consult our Prep & Injection Guide for essential preparation and safety instructions.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Week Daily Dose (mcg) Units (per injection) (mL)
Weeks 1–4 ~330 mcg daily 10 units
Weeks 5–8 ~500 mcg daily 15 units

This approach gradually increases the daily dose over 8 weeks. Reconstitute the entire 10mg blend with 3 mL of bacteriostatic water, creating a ~3.33 mg/mL solution (≈33 mcg per 1 insulin unit). For 330 mcg, draw 10 units; for 500 mcg, draw about 15 units.

Reconstitution Steps

  1. Draw 3.0 mL of bacteriostatic water into a sterile syringe.
  2. Inject water slowly along the vial wall to reduce foam formation.
  3. Gently swirl—avoid vigorous shaking.
  4. Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.

Advanced / Aggressive Approach (2 mL = 5 mg/mL)

Week Daily Dose (mcg) Units (per injection) (mL)
Weeks 1–4 500 mcg daily 10 units
Weeks 5–8 1,000 mcg (1 mg) daily 20 units

Designed for higher daily doses. Reconstitute with 2 mL of bacteriostatic water to achieve a 5 mg/mL solution (each 1 insulin unit ≈ 50 mcg). For 500 mcg, draw 10 units; for 1 mg, draw 20 units.

  1. Draw 2.0 mL of bacteriostatic water into a sterile syringe.
  2. Slowly inject the water into the vial, minimizing foam.
  3. Gently roll/swirl the vial; do not shake vigorously.
  4. Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.

Note: With daily use at 500 mcg or higher, one 10mg vial may only last 10–20 days. Plan accordingly.

Note: This guide is for educational purposes only. Always consult with a qualified healthcare professional.

Supplies Needed

Ensure you have these on hand for an 8–12 week protocol.

  • Peptide Vials (Product ID #14311):

    • Lower daily doses (~300 mcg) → 1 vial may last ~4 weeks

    • Higher daily doses (500 mcg to 1 mg) → Additional vials needed
  • Insulin Syringes: 1 syringe per injection day (30-unit or 50-unit syringes help with finer measurements)
  • Bacteriostatic Water: 1× 30ml
  • Alcohol Swabs: 1 box

Protocol Overview

A concise summary of daily or 5x-weekly scheduling for combined Ipamorelin & Tesamorelin research.

  • Goal: Investigate synergistic growth hormone support and body composition effects
  • Schedule: Once daily or 5 days on, 2 days off for 8–12 weeks
  • Dose Range: 300 mcg to 1 mg daily, depending on research objectives
  • Reconstitution: 2–3 mL is most common (5 mg/mL or ~3.33 mg/mL)
  • Storage: Keep lyophilized vials frozen and reconstituted solutions refrigerated

Dosing Protocol

Suggested daily injection approach for progressive dose escalation.

  • Daily Dose: Start ~300 mcg; gradually increase up to 500 mcg or 1 mg daily
  • Frequency: Once per day (evenings are common), or 5 days weekly
  • Cycle Length: 8–12 weeks, then assess or break before next cycle
  • Multiple Vials: Higher doses require additional vials for longer durations
  • Timing: Consistent injection times generally improve study outcomes

Storage Instructions

Proper cold storage preserves peptide integrity.

  • Lyophilized: Freeze at −20°C until ready to reconstitute
  • Reconstituted: Refrigerate at 2–8°C; do not freeze once mixed
  • Use within 30 days after mixing
  • Avoid repeated freeze-thaw cycles

Important Notes

Practical tips to enhance safety and consistency.

  • Use new, sterile syringes for each injection; rotate injection sites.
  • Track volume carefully; reconstitution volume dictates “units” per injection.
  • Consult a qualified professional before adjusting dosage or if unusual reactions occur.
  • Monitor progress throughout your research protocol, adjusting as indicated.

How This Works

Ipamorelin and Tesamorelin both influence growth hormone pathways but via distinct mechanisms.

  • Tesamorelin: A GHRH analog that stimulates the pituitary to produce GH
  • Ipamorelin: A selective ghrelin receptor agonist promoting GH release
  • Combined, they may produce a synergistic effect on IGF-1 and GH output

Potential Benefits & Side Effects

Researchers often study changes in body composition, recovery, and GH-related biomarkers.

  • May support lean muscle mass and fat reduction
  • Possible improved recovery and well-being in certain contexts
  • Side effects can include localized injection-site irritation, fluid retention, or mild GI discomfort
  • Monitor glucose levels and IGF-1 if using higher doses

Injection Technique

Subcutaneous injection guidance based on clinical best practices[7][9].

  • Clean the vial stopper and injection site with separate alcohol swabs; allow both to air-dry completely.
  • Using an insulin syringe (typically 29–31 gauge, 5/16 to 1/2 inch needle), draw up the calculated dose (10 units = 0.1 mL).
  • Select a site with adequate subcutaneous tissue (common sites include lower abdomen, thigh, or upper arm).
  • Pinch a fold of skin; insert the needle at approximately a 45° angle into the fatty subcutaneous tissue[7]. With short insulin needles, a 90° angle can also be used if injecting into a pinched skin fold.
  • Inject slowly over 2–3 seconds; do not aspirate for subcutaneous injections.
  • Withdraw needle and apply gentle pressure with a clean cotton swab; do not rub the injection site.
  • Rotate sites systematically with each injection, maintaining at least 1–2 inches spacing between sites to prevent tissue irritation.
  • Dispose of used syringes and needles immediately in a proper sharps container; never reuse needles.

Lifestyle Factors

Complementary strategies to maximize research outcomes.

  • Ensure adequate protein intake and balanced nutrition
  • Include regular resistance and cardiovascular exercise
  • Maintain proper sleep patterns and stress management

Recommended Source

We recommend Pure Lab Peptides for high-purity GLOW Peptide Blend (70 mg).

Why Pure Lab Peptides?

Important Note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

References


FDA Label (2013)
– Tesamorelin labeling update

Drugs.com
– Overview of Tesamorelin usage

FDA Label (2010)
– Initial prescribing info for Tesamorelin

Drugs.com
– Dosing guidelines for Tesamorelin
Medscape Reference
– Egrifta (Tesamorelin) prescribing details
FDA Label (2024)
– Latest Tesamorelin labeling
NCBI Bookshelf
– Clinical reference NBK548730
NCBI Bookshelf
– Clinical reference NBK539127
Mayo Clinic
– Tesamorelin subcutaneous route info
MedlinePlus
– Drug information for Tesamorelin
PMC Article
– Research article on GH peptides